Tracked deals
4
4 tracked deals across 2021-2022.
Dallas, Texas, United States
Serving employers, providers and managed care organizations, Recuro Health delivers value throughout the healthcare ecosystem with an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach.
Tracked deals
4
4 tracked deals across 2021-2022.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
4 buyout
Last 2 years
Supporting Data
Recuro Health has acquired Competitive Health to integrate CHI’s digital benefits programs into Recuro’s Digital Medical Home, expanding Recuro’s portfolio of virtual care and employer-focused benefits. The deal strengthens Recuro’s ability to deliver end-to-end digital health and integrated benefits to employer groups, carriers and TPAs across the United States.
Recuro Health, a Dallas-based digital health company, has acquired WellVia, a virtual health provider that connects patients with board-certified primary care and behavioral health clinicians. The acquisition expands Recuro's Digital Medical Home capabilities—adding virtual primary care, behavioral health, at-home lab/genomic testing and an expanded provider network—to better serve employers, payers, providers and consumers across the United States.
Recuro Health has acquired MyLegacy, a risk‑stratification and clinical decision support application developed by Family Care Path that uses Cleveland Clinic Genomic Medicine Institute guidelines. The deal integrates genetic and familial risk profiling into Recuro’s digital health platform to enhance disease management, care coordination and preventive care for employers, payers and providers.
Recuro Health, a Dallas-based digital health platform, has acquired SupDoc, an AI-enabled virtual health solution founded by Michael Brombach. The acquisition integrates SupDoc's synchronous and asynchronous telehealth capabilities into Recuro's digital medical home to expand virtual primary care and behavioral health offerings and enhance AI-driven clinical decision-making.
Turn tracked acquisition activity into an outreach-ready buyer list.